$302 Million is the total value of Wildcat Capital Management, LLC's 27 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RLX | RLX TECHNOLOGY INCsponsored ads | $65,802,000 | +19.0% | 30,893,022 | 0.0% | 21.80% | +54.1% | |
| SKLZ | SKILLZ INC | $26,824,000 | -58.7% | 21,632,157 | 0.0% | 8.89% | -46.5% | |
| ALLO | ALLOGENE THERAPEUTICS INC | $24,263,000 | +25.1% | 2,128,370 | 0.0% | 8.04% | +62.0% | |
| TDG | TRANSDIGM GROUP INC | $18,981,000 | -17.6% | 35,368 | 0.0% | 6.29% | +6.6% | |
| FB | META PLATFORMS INCcl a | $16,698,000 | -27.5% | 103,553 | 0.0% | 5.53% | -6.1% | |
| GSHD | GOOSEHEAD INS INC | $16,290,000 | -41.9% | 356,683 | 0.0% | 5.40% | -24.8% | |
| BKNG | BOOKING HOLDINGS INC | $14,711,000 | -25.5% | 8,411 | 0.0% | 4.87% | -3.6% | |
| CPNG | COUPANG INCcl a | $10,963,000 | -27.9% | 859,817 | 0.0% | 3.63% | -6.6% | |
| GPN | GLOBAL PMTS INC | $8,845,000 | -19.1% | 79,941 | 0.0% | 2.93% | +4.7% | |
| KRON | KRONOS BIO INC | $5,235,000 | -49.7% | 1,438,232 | 0.0% | 1.73% | -34.8% | |
| URGN | UROGEN PHARMA LTD | $4,366,000 | -6.0% | 533,139 | 0.0% | 1.45% | +21.7% | |
| NERDY INC | $1,167,000 | -58.1% | 547,800 | 0.0% | 0.39% | -45.7% | ||
| VACASA INC | $288,000 | -65.2% | 100,000 | 0.0% | 0.10% | -55.2% | ||
| OYST | OYSTER PT PHARMA INC | $160,000 | -62.7% | 36,847 | 0.0% | 0.05% | -51.8% | |
| ROBINHOOD MKTS INC | $114,000 | -39.0% | 13,876 | 0.0% | 0.04% | -20.8% | ||
| NERDY INC*w exp 08/16/202 | $30,000 | -75.0% | 99,600 | 0.0% | 0.01% | -67.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2022-11-08
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| COSTAR GROUP INC | 32 | Q3 2022 | 48.3% |
| UROGEN PHARMA LTD | 26 | Q3 2023 | 17.3% |
| META PLATFORMS INC | 26 | Q3 2023 | 9.9% |
| ALLOGENE THERAPEUTICS INC | 18 | Q3 2023 | 22.4% |
| GOOSEHEAD INSURANCE INC -A | 18 | Q3 2023 | 15.4% |
| SABINE RTY TRUST | 18 | Q3 2021 | 11.3% |
| LPL FINL HLDGS INC | 18 | Q1 2019 | 12.7% |
| PLAYA HOTELS & RESORTS NV | 18 | Q3 2021 | 3.4% |
| NANTKWEST INC | 17 | Q3 2019 | 22.0% |
| SORRENTO THERAPEUTICS INC | 17 | Q2 2019 | 7.0% |
View Wildcat Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Skillz Inc. | January 05, 2023 | 19,596,988 | 5.6% |
| UroGen Pharma Ltd. | February 14, 2022 | 533,139 | 2.4% |
| Skillz Inc. | March 08, 2021 | 21,832,022 | 7.5% |
| NantKwest, Inc. | February 13, 2018 | 808,974 | 1.0% |
| Sorrento Therapeutics, Inc. | February 13, 2018 | 1,738,232 | 2.2% |
View Wildcat Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-04-08 |
| SC 13G | 2024-04-08 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-09 |
| PX14A6G | 2023-11-03 |
| 13F-HR | 2023-08-11 |
| 13F-HR/A | 2023-08-10 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-07 |
| SC 13D/A | 2023-01-05 |
View Wildcat Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.